The Lewis blood group system comprises two main carbohydrate antigens, Le' and Leb. Lewis typing has traditionally been based on serologic determinations using erythrocytes and saliva. Several recent studies have demonstrated that erythrocyte Lewis phenotype may change during pregnancy or disease, and inappropriate Lewis antigens have been found in both normal and neoplastic tissue. To evaluate whether these observations are in conflict with the presently proposed genetic and biosynthetic basis of the Lewis blood group system, we performed a combined enzymatic, immunohistologic, and immunochemical study of Lewis antigen expression in normal and neoplastic tissues, as well as erythrocytes, plasma, and saliva of Le(a-b-)-typed individu-HE STRUCTURES (Table 1) of Le" and Leb determi-T nants were first deduced from serologic inhibition tests" and subsequently confirmed by isolation of oligosaccharide fragments from Le"-and HLeb-active glycoproteins isolated from ovarian cyst f l~i d s . '~, '~ Le" antigen (GalPl+ 3[Fucal-+ 41GlcNAc + R) is formed by the action of the Lewis gene-encoded a1 -+ 4-~-fucosyltransferase (a1 + 4FT) on type 1 chain (Galpl+ 3-GlcNAc + R) endings in glycoconjugates.' In tissues from individuals who encode an active a1 + 2-~-fucosyltransferase, both the galactosyl and the N-acetyl-glucosaminyl residues in the type 1 chain are substituted with L-fucose and an Leb (Fucal -+ 2Galp1 + 3-[Fucal + 41GlcNAc + R) structure is formed.I5 Lewis antigens on erythrocytes differ from ABH antigens in that they are not synthesized by the erythrocyte but rather are secondarily acquired from plasma.16 The individual Lewis phenotype has traditionally been based on serologic determinations for erythrocytes and saliva. The Lewis' phenotypes, Le(a+b-) and Le(a-b+), have been believed to result from action of a transferase encoded by an active allele Le at the Lewis locus, whereas the Lewis-phenotype, Le(a-b-), which comprises ~6 % of the white and 35% of the black population, has been believed to result from the homozygous presence of the silent allele le."
T nants were first deduced from serologic inhibition tests" and subsequently confirmed by isolation of oligosaccharide fragments from Le"-and HLeb-active glycoproteins isolated from ovarian cyst f l~i d s . '~, '~ Le" antigen (GalPl+ 3[Fucal-+ 41GlcNAc + R) is formed by the action of the Lewis gene-encoded a1 -+ 4-~-fucosyltransferase (a1 + 4FT) on type 1 chain (Galpl+ 3-GlcNAc + R) endings in glycoconjugates.' In tissues from individuals who encode an active a1 + 2-~-fucosyltransferase, both the galactosyl and the N-acetyl-glucosaminyl residues in the type 1 chain are substituted with L-fucose and an Leb (Fucal -+ 2Galp1 + 3-[Fucal + 41GlcNAc + R) structure is formed.I5 Lewis antigens on erythrocytes differ from ABH antigens in that they are not synthesized by the erythrocyte but rather are secondarily acquired from plasma. 16 The individual Lewis phenotype has traditionally been based on serologic determinations for erythrocytes and saliva. The Lewis' phenotypes, Le(a+b-) and Le(a-b+), have been believed to result from action of a transferase encoded by an active allele Le at the Lewis locus, whereas the Lewis-phenotype, Le(a-b-), which comprises ~6 % of the white and 35% of the black population, has been believed to result from the homozygous presence of the silent allele le. " Exceptions to the present concept of regulation of Lewis antigens, however, have been reported during recent years as either Lea, Leb, or both antigens have been detected in small intestine," saliva, 18 or ~rothelium'~ of individuals typed as Le(a-b-) in hemagglutination assays. Similarly, Lewis a and b antigens have been detected in various cancer tissues of RBC Le(a-b-)-typed individual^.^^^** Whether these observations are in conflict with the proposed genetic and biosynthetic basis of the Lewis blood group system is unclear because of reports demonstrating that the Lewis phenotype on RBC may change with various conditions, including carcinomas?o,2z-a With regard to breast cancer, the current lack of knowledge regarding regulation of Lewis blood group antigen expression has led to recent controversies regarding the frequency of this disease in Le(a-b-) individuals.2628 als. Of six cancer-bearing patients typed Le(a-b-), three were identified as nongenuine owing to the presence of a1 + 4fucosyltransferase activity (a1 + 4FT) and Lewis antigens in saliva and three were identified as genuine (lacking a1 -+ 4FT and Lewis antigens in saliva). These genuine Le(a-b-) individuals were shown to express significant a1 + 4FT in tissues, and Lewis antigens were detected in tissues by immunohistology as well as immunochemistry. We conclude that the Lewis phenotype obtained by serologic determination of erythrocytes and saliva does not apply to all tissues. We discuss biosynthetic and genetic consequences of this finding. @ 1991 by The American Society of Hematology.
In this study, enzymatic, immunohistologic, and immunochemical methods were used to gain insight into expression of Lewis a and b antigens and corresponding a1 + 4FT activities in individuals typed as Le(a-b-) by standard hemagglutination. Owing to the rare occurrence of Le(a-b-) individuals ( -6% of the white population), only six individuals were examined. Two groups of Le(a-b-) RBC-typed individuals were identified. One group (consisting of three individuals) was classified as nongenuine Le(a-b-) (a1 -+ 4FT activity detected in saliva); the other (also consisting of three individuals) was classified as genuine Le(a-b-) (no a1 + 4FT activity detected in saliva). The nongenuine Le(a-b-) individuals had chemical amounts of Lewis active neutral glycolipids in their RBC and serum similar to Lewis' individuals, regardless of lack of hemagglutination. In the genuine Le(a-b-) group, none or very small quantities of Lewis a and b antigens were 1390 ORNTOFT ET AL 'The LeE antigen has been reported to be an elongated variant of the basic Gal pl+3GlcNAcp disaccharide with the type-2 chain Le" hapten."
found on RBC or in serum, whereas Lewis antigens and low but readily detectable a1 -+ 4FT activity were found in colon and bladder tissues.
MATERIALS AND METHODS

Samples.
Fifty-milliliter samples of human whole blood were obtained from six individuals by venipuncture, partly used within 24 hours for serology, and partly centrifuged and stored at -80°C as serum and cells. Saliva was obtained simultaneously with the blood samples, and 1 mL was stored at -80°C for enzyme analysis and 1 mL was boiled and stored at -20°C for hemagglutination inhibition studies. Biopsies were taken from colon tumors as well as morphologically and microscopically normal colonic mucosa far from the tumor. From two individuals, biopsies were obtained from transitional cell carcinomas of the urinary bladder. All biopsies were immediately frozen at -80°C.
RBC were grouped by use of polyclonal human, rabbit, and goat antisera (Ortho Diagnostic Systems, Raritan, NJ) as well as Dolichos biflom and Ulex europaeus agglutinin (Sigma Chemical, St Louis, MO) according to routine blood bank procedure. Identical sera and lectins were used to detect Lewis substance in saliva by low-ion-strength hemagglutination inhibition. In all assays, appropriate known controls were included.
Saliva was thawed and frozen twice and centrifuged at 800g, and the supernatant was used for assays. For assays of a1 + 31T and a1 + 4lT, 20 pL enzyme source was added to GDP-L-[*~C]-FUC (0.28 nmol, 70,000 cpm), MnCl, (1 pmol), acceptor (0.5 pmol), ATP (0.5 pmol), Triton X-100 (500 pg), and 0.1 mol/L Tris-HCI (pH 7.2) in a total volume of 100 pL. The mixture was incubated for 2 hours and chromatographed on Serology.
FT assays on saliva.
Whatman no. 40 paper in ethyl acetate/pyridine/water ( 1 0 4 3 vol/vol/vol) for 48 hours. The papers were dried, scanned for radioactivity (Packard radiochromatogram scanner, Downersgrove, IL), and the mobility of peaks was measured relative to known compounds; these areas were then cut out and counted by a liquid scintillation counter. N-Acetyllactosamine (Galpl + 4GlcNAc) was used as acceptor for the a1 4 31T determination, and lacto-N-biose I (Galpl 4 3GlcNAc) was used as acceptor for the a1 + 41T.29
Tissue samples ( = 1 g) were homogenized in 2 vol50 mmol/L HEPES buffer (pH 7.2), 0.5 m o w sucrose, and 1 mmol/L EDTA by two strokes of a Potter-Elvehjem homogenizer and used for characterization of enzyme activities present in each fraction. The FT activity was determined as previously described"' in reaction mixtures containing 2.5 pmol HEPES buffer (pH 7.2), 40 pg lactotetraocyclceramide (Galpl-3GlcNAc~1-3Gal~l-4Glcp1-1Cer) (Lc4) or lactoneotetraosylceramide ( G a l p l4GlcNAcpl-3Galpl-4G1cpl-1Cer) (nLc,), 100 pg taurodeoxycholate, 1 pmol MnCI,, 0.5 pmol CDP-choline, 15 nmol GDP-['4C]-Fuc (15,000 cpndnmol), and 100 to 300 pg protein in a total volume of 0.1 mL. The reaction mixture was incubated for 2 hours at 37°C and terminated by addition of 6 pmol EDTA and 0.1 mL chloroform-methanol (CM) 21. The entire reaction mixture was streaked onto a 4-cm-wide strip of Whatman no. 3 paper and chromatographed with water overnight. The glycolipid remaining at the origin was extracted with 2-to 5-mL washes of chloroformmethanol-water (CMW) 10:5:1. The solvent was removed by nitrogen stream, and the glycolipid was dissolved in 20 pL CM 21. A 10-pL aliquot was removed, spotted onto an high-performance thin-layer chromatography (HPTLC) plate (Merck, Darmstadt, FRG), and developed in CMW 605:l containing 0.02% CaCl, as a FT assay on tissues.
For personal use only. SOOg for 20 minutes. The insoluble pellet was re-extracted twice in an identical way, and the combined supernatants were evaporated under nitrogen stream. The near-dry samples were then dissolved in CMW 30603 and subjected to chromatography on diethylaminoethanol (DEAE) Sephadex A -2 9 to separate total neutral glycolipids from gangliosides. The total neutral glycolipid fraction was dried and acetylated with 1 mL pyridine and 0.5 mL acetic anhydride, followed by chromatography on a Florisil column and deacetylation with s-vol 0.5% sodium methoxide in CM 21. The samples were dried and resuspended in CM 21, and 5 JLL of this total neutral glycolipid fraction was spotted on HPTLC plates, developed in CMW 5040:10, and stained with orcinol. The amount of glycolipid in each lane was standardized according to the extent of orcinol staining.
Immunostaining of glycolipids separated by HPTLC was performed according to the procedure of Magnani et allz as modified by Kannagi et The monoclonal antibodies (MoAbs) used were anti-le" clone CF4-C, (IgG,)34 and anti-Leb (IgM) donated by Dr Donald A. Baker (Chembiomed, Alberta, Canada). TLC immunostaining with the anti-Leb MoAb produced staining in the hexaosylceramide region. In glycolipid extracts of tissues, staining of the H type 1 pentaosylceramide region was also observed, indicating cross-reactivity with H type 1 structures. Only one anti-Leb MoAb was used for TLC immunostaining studies owing to the limited amount of lipid extract available.
Immunohistochemistry. Immunohistochemical studies were performedwith two additional IgM anti-Leb MoAbs: one from BiotestSerum Institut, GMBH, Frankfurt, FRG, the second donated by L. Messetter, Malm@ Hospital, Sweden. The specificity of the latter MoAb has been studied in detail?5 An IgG, MoAb, FH7:6 directed to the sialosyl derivative of Le" (sialosyl-Le;,), was also used.
A modification of previously described methods3'." was used.
Isolation of glycolipids.
TLC immunostaining.
Formalin-fixed, paraffin-embedded 3-km sections were deparaffinized and rehydrated. 
RESULTS
Genuine &(a -b-) individuals.
Three individuals were identified as genuine Lewis-negative individuals because their RBC typed Le(a-b-) and their saliva contained no a1 -+ 4FT activity (Table 2) . Normal colon and colonic cancer tissue was available from only two of three and in one only bladder cancer tissue was available. Normal colon tissue and bladder tumor tissue from Lewis-positive individuals served as control.
In normal colonic mucosa, colon carcinoma tissue, and bladder cancer tissue, a1 + . 4FT activity was readily detectable with the type-1 chain glycolipid acceptor Lc4 ( Table 2 ). The specific activity of the a1 + 4FT was similar in all five specimens examined and considerably lower (5% to 16%) than the activity in Lewis-positive controls (Table 2) .
In contrast, significant a1 + . 3Fuc transfer into the type-2 chain glycolipid acceptor nLc, occurred in all samples regardless of Lewis status of donor. TLC analysis of reaction products from transfer of I4C-Fuc from GDP-[I4C]-Fuc to the type-1 chain acceptor Lc4 and the type-2 chain FT activity of tissue from Le(a-b-) individuals. *Hemagglutination with polyclonal sera, Dolichos biflorus, and Ulex europaeus lectins defined RBC phenotype; hemagglutination inhibition was used to determine titer in saliva.
tSaliva was incubated with GDP-L-["CI-FUC (0.28 nmol, 70,000 cpm), MnCI, (1 pmol), acceptor (0.5 kmol) lacto-N-biose I (al-4FT) or N-acetyllactosamine (al-3FT). ATP (0.5 pmol), Triton X-100 (500 kg), and 0.1 mol/LTris-HCI (pH 7.2) in a total volume of 100 pL.
SHEPES buffer (pH 7.2) 2.5 pmol, Lc, or nLc,40 pg. taurodeoxycholate 100 pg, MnCI, 1 pmol, CDP-choline 0.5 pmol, GDP-[14C]-Fuc 15 nmol(l5,OOO cpdnmol), and 100 to 300 pg protein in a total volume of 0.1 ml. Material for assay was homogenized in 50 mmol/L HEPES buffer (pH 7.2). 0.5 mol/L sucrose, and 1 mmoVL EDTA. §Anti-lea and three different anti-Leb MoAbs were used to demonstrate Lewis structures on tissue sections and TLC. Similar staining was observed with the three anti-Leb MoAbs.
For personal use only. on April 2, 2017. by guest www.bloodjournal.org From 1392 0RNTOFT ET AL active glycolipids when total neutral glycolipids wcre extracted from RBC and serum and subjected to immunochemical characterization (Fig 2A) . Normal and malignant tissuc spccimcns examined by this mcthod all Contained pcntasaccharidc Le' and hcxasaccharidc Leh antigens however, (Fig 2A) . Thcsc findings wcre furthcr supported by immunohistochemical dctcction of Lewis antigcns on tissue scctions (Fig 3) from all fivc spccimcns. Thc prcscncc of small quantities of Le' and Leh activc glycolipids in RBC extracts of thc bladder carcinoma patient (Fig 2A, B,   samplcs FT activity in tissue from non-genuine Le(a 4-) individuah. In thc two spccimcns of normal colon mucosa, an a1 -4FT activity similar to that in the Lewis positive control group (Table 2) was detcctcd (Table 3 ). In thc bladder carcinoma, the al + 4FT activity was in the same rangc as that of gcnuinc Lewis-negativc individuals (Tablc 3). The a1 -3FT was activc to an cxtcnt similar to that of the other individuals examined (Tablc 3).
Lewis antigens in tissues jivm nongenuine L.e(a-b-) individuals. lmmunostainingof extracted total neutral glycolipids showed pcntasaccharide Le' and hexasaccharidc Leh antigens in tissues, and interestingly, also in RBC and scrum although RBC could not bc agglutinated by antiLewis sera (Fig 3B) . As cxpcctcd, immunohistology showcd Lewis antigcns in these individuals (Tablc 3). 2 and 4) . as was a product corrcsponding to a1 -2 fucosylation of the terminal Gal of Lc, (lanes   1 and 3) . most probably associated with thc sccrctor gcnc status of the donors. Fucose transfer in a1 -4 linkagc to Lc, rcsultcd in a strong band with the Lewis-positivc donor (Fig 1, lane 1) . which was greatly reduced but still dctcctablc with the genuinc Lewis-ncgativc donor (Fig 1, lanc 3) . Further analysis of thc isolated band corrcsponding to III'FucLc, from the Lewis-negative donor was conducted by TLC analysis of the acetylated derivative." Thc acctylated product comigrated with standard III'FucLc, but not III'FucnLc,, indicating that the product Contained an a1 -4 linked Fuc on Lc, (data not shown). The rclativc intensity of thc bands reflects the competition betwccn the a1 -4FT and a1 -21T for their mutual acceptor Lc4 and that of the a1 -3FT and a1 -2FT for their mutual acceptor nLc,. In the former case, the a1 -4FT dominatcs in Lewis-positive individuals (Fig 1, lane 1) . whereas the a1 -2FTdominates in Lewis-negative individuals (Fig 1, lane 3) .
In the latter case, the a1 -* 3FT is so strongly expressed in most individuals as comparcd with a1 -* 2FT that only insignificant amounts of a1 + 2-fucosylated products are formed (Fig I, lanes 2 and 4) .
Lewis antigens in tissues of genuine L.e(a-b-) individuals.
The genuine Le(a-b-) status of the examined individuals was confirmed by the nearly complete absence of Lewis In the group of gcnuinc Le(a-b-) individuals, we were ablc to idcntify Lewis a and b antigens and detect low a1 -* 4FT activity in colon and bladder tissue, indicating in vivo activity of the a1 -4FT. In the group of nongenuine Lc(a-b-) individuals, an al -4FT activity corrcsponding to that detected in Lewis-positivc individuals, as well as Lewis antigens, were dctcctcd in colon and bladder. Owing to grcat individual variation in enzyme activity, homozygous and heterozygous individuals cannot be scparatcd, but the relatively high frequency of heterozygous (Le, le; IC, Le) individuals in the population makes it unlikely that the rclativcly rare nongcnuinc Le(a-b-) individuals should simply be the heterozygous individuals. The finding of a1 + 4FT activity leading to formation of Lewis antigens in vivo in genuine Le (a-b-) individuals is of interest because such persons are assumed to be homozygous for an inactive allele le at the Lewis gene locus. The operational definition for Lewis-positive and Lewisnegative individuals does not specify any mechanism for the observed differential expression, however. In view of our results, the distinction between Lewis-positive and Lewisnegative individuals does not appear to be qualitative and alternate mechanisms for differential expression might be proposed as follows. Third, a probably more likely alternative involves an analogy to the blood group A subgroups. Some members of such subgroups inherit an A gene coding for an A transferase with high acceptor affinity (A, transferase), whereas others inherit a gene coding for an enzyme with lower acceptor affinity and more restricted substrate specificity (A, transferase), yielding different levels of cell surface A antigen characterizing the phenotype.44345 Although current knowledge regarding number and specificities of a1 + %FTs is a m b i g u o u~,~-~.~ a1 + % transfer apparently is ascribable to the same protein, based on kinetic data? In addition, in recent studies using gene expression data in which human DNA was transfected into COS-1 cells, an enzyme with both a1 + 3-(N-acetyllactosamine as acceptor) and a1 + 4FT activity was identified and expressed (John B. Lowe, personal communication, March 1990). By similar techniques, an a1 + 3FT activity with no a1 + 4FT activity was recently identified.47 If the number of FT genes is limited to the presently identified Lewis (a1 + %FT) and " X ' (a1 + 3 R ) , the Lewis gene probably comprises several variants similar to the blood group A genes, with differing relative reactivities to type-1 and type-2 chain acceptors.
The specific mechanism for the expression of Lewis a and b antigens in Lewis-negative individuals is complex and still unresolved. Although a few individuals were studied, however, we conclude that RBC and saliva Lewis blood group phenotype do not provide complete information regarding the Lewis phenotype in epithelia in general, most likely owing to Lewis gene-encoded transferase proteins with variable activity.
